Back

How can we protect patients long-term after a percutaneous coronary intervention (PCI)?

31 August 2020 (18:45 - 18:55)
Organised by:
Congress Presentation Part of: Towards a new standard of care in coronary and peripheral artery disease: from trial results to guidelines and beyond Treatment Open Access ESC Congress 2020

About the speaker

Photo
Professor Robert Welsh

Mazankowski Alberta Heart Institute, Edmonton (Canada)

5 More presentations in this session

Presentation thumbnail
Welcome and introduction.
Professor R. Welsh (Edmonton, CA)
Video
Presentation thumbnail
Protecting the patient that needs more: moving from ‘stable coronary artery disease’ to ‘chronic coronary syndromes’.
Professor J. Steffel (Zurich, CH)
Video
Presentation thumbnail
Protecting the patient undergoing lower extremity revascularization for symptomatic PAD.
Professor M. Bonaca (Aurora, US)
Video
Presentation thumbnail
Optimizing protection for patients with symptomatic chronic peripheral artery disease.
Professor M. Brodmann (Graz, AT)
Video
Presentation thumbnail
Live Questions and Answers and closing.
Video

Access the full session

Session thumbnail
Towards a new standard of care in coronary and peripheral artery disease: from trial results to guidelines and beyond
Video

The Event

Event poster

ESC Congress 2020

31 August 2020 18:45 CET
You may be interested in
thumbnail
Congress Presentation
Rethinking interventional cardiology in stable ischaemic heart disease
27 August 2022
thumbnail
Congress Presentation
Patients adherence to the therapy after acute coronary syndrome undergoing PCI and its impact on hospitalizations and all- cause mortality during one year of follow up
29 June 2021
thumbnail
Congress Session
Dual antiplatelet therapy titration after percutaneous coronary intervention: when to escalate, de-escalate, withdraw, and more
28 August 2023
thumbnail
Congress Presentation
Long-term outcomes in patients with chronic coronary artery disease undergoing percutaneous coronary intervention of calcified lesions with angiographic visible calcium
29 August 2025

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources